Steven Nathan, MD, and Imre Noth, MD, provide their insights into the challenging management of patients with an interstitial lung disease (ILD). They discuss key considerations in the diagnosis and differential diagnosis of an ILD and the evolution in individualized treatment, including palliative care.
- Definition and epidemiology
- Evaluation and diagnosis
- Nonpharmacologic and pharmacologic treatment
- Acute exacerbations
- Palliative care
- Future directions
This activity was developed for pulmonologists, rheumatologists, and other clinicians who may encounter patients with interstitial lung diseases (ILDs) and/or connective tissue diseases (CTDs).
Director, Advanced Lung Disease and Lung Transplant Programs
Inova Fairfax Hospital
Chief of Pulmonary & Critical Care Medicine
Professor of Medicine
University of Virginia School of Medicine
1.50 AMA PRA Category 1 Credits™.
1.50 AANP Contact Hours
|Opens:||October 31, 2018|
|Expires:||October 30, 2019|
Other Healthcare Providers